Načítá se...
Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets
Ovarian cancer remains the most fatal gynecologic malignancy worldwide due to delayed diagnosis as well as recurrence and drug resistance. Thus, the development of new tumor-related molecules with high sensitivity and specificity to replace or supplement existing tools is urgently needed. Cancer-tes...
Uloženo v:
| Vydáno v: | J Ovarian Res |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6318940/ https://ncbi.nlm.nih.gov/pubmed/30609934 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-018-0475-z |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|